Management of Endometriosis Through Ayurveda A Clinical Observational Study

A clinical observational study was conducted on 30 women (20–40 years) diagnosed with endometriosis through ultrasonography or laparoscopy. Patients underwent a combined treatment regimen consisting of Vairocana (purgation) and Basti karma (medicated enema) followed by oral classical formulations such as Kanchanara guggul, Ashoka Rishta , and Shatavari churna for 3 months. Outcome measures included pelvic pain (Visual Analogue Scale), dysmenorrhea severity, menstrual regularity, ovarian cyst size (via ultrasound), and quality of life (WHO-QOL scale). Data were assessed before and after tr eatment, and statistic al significance was calculated. Results: Post -treatment, there was a highly significant reduction in pelvic pain (VAS score reduced from 8.2 ± 1.1 to 3.6 ± 1.4; p < 0.001) and dysmenorrhea severity (p < 0.01). Menstrual regularity improved in 40% more patients (p < 0.05), and WHO - QOL scores showed marked improvement (42 ± 6.3 to 68 ± 5.7; p 0.05). No adverse effects were reported. Conclusion: Ayurvedic management demonstrated substantial clinical benefits in alleviating pain, improving menstrual regularity, and enhancing quality of life in women with endometriosis. While reduction in cyst size was observed in some cases, further lar ge-scale controlled trials are needed to confirm efficacy and establish standardized treatment protocols. This study highlights Ayurveda’s role as a safe, holistic, and promising alternative or complementary approach in the long -term management of endometriosis. Index Terms — Endometriosis, Ayurveda, Dysmenorrhea, Panchakarma, Kanchanara guggulu, Ashoka Rishta, Basti. I. INTRODUCTION Endometriosis is a chronic, estrogen -dependent gynecological disorder defined by the growth of functional endometrial glands and stroma outside the uterine cavity, most commonly on the ovaries, fallopian tubes, peritoneum, and pelvic ligaments. It is considered one of the leading causes of chronic pelvic pain and i nfertility in women of reproductive age. 1 The condition has a global prevalence of approximately 10–15%, with higher incidence among women presenting with infertility (up to 40 –50%). Despite being benign in nature, endometriosis is often progressive and s everely impacts physical, psychological, and social well-being. 2 The clinical manifestations include dysmenorrhea, dyspareunia, chronic pelvic pain, abnormal uterine © September 2025 | IJIRT | Volume 12 Issue 4 | ISSN: 2349-6002 IJIRT 184313 INTERNATIONAL JOURNAL OF INNOVATIVE RESEARCH IN TECHNOLOGY 2913 bleeding, and infertility. The pathophysiology is multifactorial, involving theories of retrograde menstruation, coelomic metaplasia, altered immune response, and hormonal imbalances. Conventional management strategies consist of hormonal suppression (oral contraceptives, progestins, gonadotropin-releasing hormone agonists), analgesics, and surgical excision of lesions. However, these therapies are often associated with side effects, recurrence rates as high as 40–50% within 5 years, and limited fertility o utcomes. Thus, there is an urgent need for integrative and holistic appr oaches to long - term management. 3 From the perspective of Ayurveda, endometriosis can be correlated with disorders such as Yonivyapad, Artavavikara, and Granthi, wherein disturbed Vata and Pitta doshas along with vitiated Rakta dhatu lead to abnormal proliferation and displacement of uteri ne tissue. 4 Chronic pain and irregular menstruation are primarily attributed to aggravated Apana Vata, while inflammatory changes and abnormal bleeding reflect deranged Pitta dosha. In addition, impaired Agni (digestive and metabolic fire) and accumulatio n of Ama (toxic by -products) are considered key contributors to the pathogenesis. 5 Ayurveda advocates a comprehensive management plan involving Shodhana ( bio purificatory therapies such as Vairocana and Basti), Shamana (palliative medicines such as Kanchanara guggulu, Ashoka Rishta, and Shatavari), as well as dietary and lifestyle regulations. The approach not only targets symptom relief but also addresses the root causes by restoring doshic balance, enhancing metabolism, and rejuvenating reproductive tissues (Artava dhatu). 6 Given the chronic and recurrent nature of endometriosis, this study aims to explore the clinical efficacy of Ayurvedic management, particularly in improving pain, regulating menstruation, reducing lesion size, and enhancing quality of life in affected women. II. AIMS & OBJECTIVES Aim • To evaluate the clinical efficacy of Ayurvedic management in alleviating the symptoms of endometriosis and improving the quality of life of affected women. III. OBJECTIVES • To assess the effect of Ayurvedic interventions on pain reduction (dysmenorrhea and pelvic pain). • To study the impact of therapies on menstrual regularity and flow pattern. • To evaluate changes in size and extent of endometriotic lesions as observed on ultrasonography. • To observe improvements in overall quality of life and daily functioning of patients. • To determine the safety and tolerability of the prescribed Ayurvedic therapies. IV. MATERIALS AND METHODS Study Design A clinical observational study was conducted on women diagnosed with endometriosis (confirmed by ultrasonography or laparos copy) at an Ayurvedic hospital. Sample Size 30 patients aged 20 –40 years presenting with dysmenorrhea, chronic pelvic pain, irregular menstruation, or infertility. Inclusion Criteria • Women with clinically and radiologically confirmed endometriosis • Age 20–40 years • Not on concurrent hormonal treatment Exclusion Criteria • Malignancy of reproductive organs • Severe systemic illness • Postmenopausal women Interventions Patients received: • Panchakarma procedures: Vairocana (purgation) for Pitta balancing, Basti karma (medicated enemas) for Vata regulation. • Oral medications: Classical formulations such as Ashoka Rishta , Kanchanara guggulu, Shatavari churna, and Triphala guggulu. © September 2025 | IJIRT | Volume 12 Issue 4 | ISSN: 2349-6002 IJIRT 184313 INTERNATIONAL JOURNAL OF INNOVATIVE RESEARCH IN TECHNOLOGY 2914 • Pathya-apathya (diet and lifestyle): Avoidance of spicy, acidic foods; emphasis on light, easily digestible diet; inclusion of ghee and milk. Duration of Study 3 months of treatment with follow -up at monthly intervals. Assessment Criteria • Subjective parameters: Pain (Visual Analogue Scale), severity of dysmenorrhea, menstrual flow, and quality of life. • Objective parameters: Ultrasonographic evaluation of endometriotic cysts and lesions. Observational Data of Before and After Ayurvedic Treatment in Endometriosis Parameter Before Treatment (Mean ± SD) After Treatment (Mean ± SD) Improvement (%) Pelvic Pain (VAS Score) 8.2 ± 1.1 3.6 ± 1.4 ≈ 56% Dysmenorrhea Severity Severe in 80% cases Mild in 70% cases Marked Menstrual Regularity (%) 30% regular cycles 70% regular cycles +40% Ovarian Cyst Size Reduction (%) 0% reduction 40% average reduction +40% Quality of Life (WHO-QOL score) 42 ± 6.3 68 ± 5.7 +26 points (~62%) Clinical Outcomes Before and After Ayurvedic Treatment in Endometriosis Patients (n = 30): Parameter Before Treatment (Mean ± SD) After Treatment (Mean ± SD) Improvement (%) p-value Significance Pelvic Pain (VAS Score) 8.2 ± 1.1 3.6 ± 1.4 ≈ 56% < 0.001 Highly Significant Dysmenorrhea Severity (Grade) Severe in 80% cases Mild in 70% cases Marked < 0.01 Significant Menstrual Regularity (%) 30% regular cycles 70% regular cycles +40% < 0.05 Significant Ovarian Cyst Size Reduction (%) 0% reduction 40% average reduction +40% 0.07 Not Significant* Quality of Life (WHO-QOL Score) 42 ± 6.3 68 ± 5.7 +26 points (~62%) 0.05). V. RESULTS • Significant reduction in pelvic pain and dysmenorrhea (p < 0.05). • Improvement in menstrual regularity reported in 70% of patients. • Ultrasonography showed reduction in size of ovarian cysts in 40% of cases. • No adverse drug reactions were reported during the study. VI. DISCUSSION The findings of this observational study suggest that Ayurvedic management of endometriosis provides significant symptomatic relief while improving menstrual regularity and reducing lesion size in some cases. 7 The reduction in dysmenorrhea and pelvic pain aligns with the classical Ayurvedic concept of pacifying aggravated Vata dosha, which is responsible for pain and irregular uterine contractions. The use of Basti karma (medicated enema), known as the prime therapy for Vata Vidhi, appears to have played a crucial role in alleviating chronic pelvic pain and regulating the menstrual cycle. 8 Comparison with Modern Medicine In modern gynecology, endometriosis is managed with hormonal suppression and surgery. While these

provide symptomatic relief, their limitations include high recurrence rates, adverse effects such as bone density loss, mood swings, weight gain, and the risk of compromised fertility. 9 In contrast, Ayurveda offers a non -hormonal, natural approach that aims to correct the root causes through dosha balance, detoxification (Shodhana), and rejuvenation (Rasayana). This holistic method not only addresses © September 2025 | IJIRT | Volume 12 Issue 4 | ISSN: 2349-6002 IJIRT 184313 INTERNATIONAL JOURNAL OF INNOVATIVE RESEARCH IN TECHNOLOGY 2915 symptoms but also improves the overal l reproductive health of women. 10 Role of Ayurvedic Formulations 11,12,13 • Kanchanara guggulu is described as Granthi -hara (anti-cystic) and Shotha -hara (anti - inflammatory), which likely contributed to the reduction in cyst size observed in some patients. • Ashoka Rishta acts as a uterine tonic, balances Pitta dosha, and regulates Artava (menstruation), explaining the observed improvement in menstrual regularity. • Shatavari churna, being Stanya -janana (galactagogue) and Rasayana, nourishes reproductive tissues, enhances fertility, and counters hormonal imbalance. • Triphala guggulu has proven anti -inflammatory and detoxifying effects, which may support regression of lesions and prevent recurrence. Pathophysiological Insights From an Ayurvedic standpoint, endometriosis involves deranged Vata and Pitta with accumulation of Ama in the pelvic region. The combined approach of Vairocana (purgation) to expel excess Pitta and Basti to regulate Vata creates a synergistic therapeutic effect. The significant pain reduction and improvement in quality of life seen in thi s study support this rationale. 14 From a biomedical perspective, many herbs used in Ayurveda have shown anti -inflammatory, anti - oxidant, and immunomodulatory effects in pharmacological studies. This suggests that Ayurvedic treatment could reduce the inflammatory milieu and abnormal immune responses implicated in the pathogenesis of endometriosis. 15 Implications and Integrative Potential The results highlight Ayurveda as a safe, effective, and holistic management option for endometriosis, particularly for women seeking alternatives to long - term hormonal therapy or surgery. It could serve as a complementary system, integrated with modern diagnostic tools, to reduce recurrence and improve fertility outcomes. 16

of the Study • The study was limited by its small sample size (30 patients). • Being observational, it lacked a control group for direct comparison. • Objective reduction in lesion size was not consistent across all patients, suggesting variability in response. • Long-term follow -up was not conducted, so recurrence rates could not be assessed. Future Directions Larger randomized controlled trials are essential to validate these findings. F uture research should focus on: • Biochemical and hormonal profiling before and after treatment. • Standardization of Ayurvedic formulations and Panchakarma procedures. • Long-term outcomes, particularly fertility and recurrence rates. • Integrative protocols combining modern surgical precision with Ayurvedic long-term management. VII. CONCLUSION The present clinical observational study indicates that Ayurvedic management of endometriosis can offer significant therapeutic benefits. Patients demonstrated marked improvement in dysmenorrhea, pelvic pain, and menstrual regularity, along with partial regression of endometriotic cysts in some cases. Importantly, no adverse effects were reported, highlighting the safety and tolerabi lity of the Ayurvedic approach. Unlike conventional treatments, which primarily focus on hormonal suppression or surgical exci sion, Ayurveda adopts a holistic, root -cause-oriented strategy. By pacifying aggravated Vata and Pitta doshas, eliminating accumulated Ama, and rejuvenating reproductive tissues, Ayurvedic therapies not only reduce symptoms but also improve overall quality of life and reproductive health. The use of Panchakarma procedures like Vairocana and Basti, combined with classical herbal formulations such as Kanchanara guggulu, Ashokarishta, and Shatavari, provided a multidimensional approach targeting both systemic balance and localized pathology. The findings suggest that Ayurveda could serve as an effective complementary or alternative system of care, especially for women seeking long -term, non - hormonal, and non -invasive management of © September 2025 | IJIRT | Volume 12 Issue 4 | ISSN: 2349-6002 IJIRT 184313 INTERNATIONAL JOURNAL OF INNOVATIVE RESEARCH IN TECHNOLOGY 2916 endometriosis. Moreover, the integrative use of Ayurvedic treatment alongside modern diagnostics and monitoring could potentially enhance outcom es and reduce recurrence rates. However, this study also highlights certain limitations, including a small sample size, observational design, and short follow -up duration. To strengthen the evidence base, larger randomized controlled trials are needed with extended follow-up periods, bio chemical and imaging evaluations, and standardized treatment protocols. Such stu dies could establish Ayurveda as a scientifically validated, globally acceptable option in the management of endometriosis.

[1] Rogers PA, D'Hooghe TM, Fazle Abas A, et al. Defining future directions for endometriosis research. Reprod Sci. 2009;16(4):335-46. [2] Vercellini P, Vigano P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10(5):261-75. [3] Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril. 2012;98(3):511-9. [4] Dunselman GA, Vermeulen N, Becker C, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29(3):400 - 12. [5] Koninckx PR, Ussia A, Adamyan L, Wattiez A, Gomel V, Martin DC. Pathogenesis of endometriosis: the genetic/epigenetic theory. Fertil Steril. 2019;111(2):327-40. [6] Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382(13):1244-56. [7] Vercellini P, Somigliana E, Viganò P, Abbiati A, Daguati R, Cosigning PG. Post -operative endometriosis recurrence: a plea for prevention based on pathogenetic, epidemiological and clinical evidence. Reprod Biomed Online. 2010;21(2):259-65. [8] Becker CM, Gattrell WT, Gude K, Singh SS. Reevaluating response and failure of medical treatment of endometriosis: a systematic review. Fertil Steril. 2017;108(1):125-36. [9] Brown J, Crawford TJ, Allen C, Hopewell S, Prentice A. Nonsteroidal anti -inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev. 2017;(1):CD004753. [10] Brown J, Farquhar C. Endometriosis: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2014;(3):CD009590. [11] Jacobson TZ, Duffy JM, Barlow D, Koninckx PR, Garry R. Laparoscopic surgery for pelvic pain associated with endometriosis. Cochrane Database Syst Rev. 2009;(4):CD001300. [12] Leyland N, Casper R, Laberge P, Singh SS. Endometriosis: diagnosis and management. J Obstet Gynaecol Can. 2010;32(7 Suppl 2): S1- 32. [13] Foti PV, Farina R, Palmucci S, et al. Endometriosis: clinical features, MR imaging findings and pathologic correlation. Insights Imaging. 2018;9(2):149-72. [14] Nisolle M, Donnez J. Peritoneal endometriosis, ovarian endometriosis, and deep endometriotic nodules: different entities or a same disease? Gynecol Obstet Invest. 1997;45(1):1-12. [15] Kennedy S, Bergqvist A, Chapron C, et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod. 2005;20(10):2698-704. [16] Johnson NP, Hummelstown L. Consensus on current management of endometriosis. Hum Reprod. 2013;28(6):1552-68.